NCT02783573 A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia Status TERMINATED Phase PHASE3
NCT02779751 A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02778126 A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02778113 A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults Status COMPLETED Phase PHASE1
NCT02778100 A Study of Nasal Glucagon in Participants With a Common Cold Status COMPLETED Phase PHASE1
NCT02770521 A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT02763566 A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02760602 A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02759107 A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) Status COMPLETED Phase PHASE1
NCT02758613 A Study of Baricitinib (LY3009104) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT02758171 Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02757352 A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE3
NCT02754830 A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) Status COMPLETED Phase PHASE1
NCT02752087 A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02750410 A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02747004 A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02745769 A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents Status COMPLETED Phase PHASE1